tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market
PCRX
Pacira Pharmaceuticals
RESEARCH TOOLSreports
Want to see PCRX full AI Analyst Report?

Pacira Pharmaceuticals (PCRX) Ratios

384 Followers

Pacira Pharmaceuticals Ratios

PCRX's free cash flow for Q1 2026 was $―. For the 2026 fiscal year, PCRX's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.73 4.54 2.40 5.24 3.37
Quick Ratio
 3.35 3.28 2.00 4.17 2.72
Cash Ratio
 1.33 1.31 0.89 1.57 0.70
Solvency Ratio
 0.14 0.17 -0.03 0.17 0.12
Operating Cash Flow Ratio
 1.31 1.26 0.61 1.59 0.98
Short-Term Operating Cash Flow Coverage
 14.49 15.45 0.94 17.90 4.32
Net Current Asset Value
$ -23.83M$ -23.83M$ -30.04M$ -194.26M$ -407.86M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.36 0.41 0.37 0.45
Debt-to-Equity Ratio
 0.02 0.66 0.82 0.67 0.99
Debt-to-Capital Ratio
 0.01 0.40 0.45 0.40 0.50
Long-Term Debt-to-Capital Ratio
 0.00 0.37 0.33 0.37 0.46
Financial Leverage Ratio
 1.85 1.82 2.00 1.81 2.17
Debt Service Coverage Ratio
 5.15 4.01 -0.03 5.20 2.07
Interest Coverage Ratio
 3.11 1.61 -4.43 5.06 1.69
Debt to Market Cap
 0.01 0.36 0.67 0.33 0.39
Interest Debt Per Share
 0.44 10.59 14.17 13.05 17.55
Net Debt to EBITDA
 2.43 2.48 12.43 2.80 4.70
Profitability Margins
Gross Profit Margin
60.15%71.50%75.69%72.64%70.11%
EBIT Margin
2.59%3.87%-7.09%11.71%7.33%
EBITDA Margin
13.04%16.40%4.15%22.90%21.05%
Operating Profit Margin
3.40%3.87%-10.47%12.99%9.00%
Pretax Profit Margin
1.79%2.32%-9.00%9.14%1.99%
Net Profit Margin
1.27%0.97%-14.20%6.22%2.39%
Continuous Operations Profit Margin
1.27%0.97%-14.20%6.22%2.39%
Net Income Per EBT
70.65%41.69%157.77%68.00%119.60%
EBT Per EBIT
52.76%60.04%86.01%70.37%22.16%
Return on Assets (ROA)
0.56%0.56%-6.41%2.66%0.95%
Return on Equity (ROE)
0.95%1.01%-12.79%4.82%2.05%
Return on Capital Employed (ROCE)
1.75%2.46%-5.90%5.94%3.91%
Return on Invested Capital (ROIC)
0.72%1.02%-5.05%3.99%3.81%
Return on Tangible Assets
0.80%0.80%-8.83%4.52%1.63%
Earnings Yield
0.66%0.61%-11.43%2.69%0.91%
Efficiency Ratios
Receivables Turnover
 5.85 5.85 6.19 6.39 6.78
Payables Turnover
 8.24 13.67 8.91 11.76 13.09
Inventory Turnover
 0.77 1.35 1.36 1.77 2.07
Fixed Asset Turnover
 4.18 3.98 3.24 2.87 2.62
Asset Turnover
 0.61 0.57 0.45 0.43 0.40
Working Capital Turnover Ratio
 1.76 1.68 1.65 1.77 1.92
Cash Conversion Cycle
 368.70 305.12 286.33 232.31 201.92
Days of Sales Outstanding
 62.34 62.34 59.00 57.08 53.86
Days of Inventory Outstanding
 340.07 269.49 268.31 206.25 175.94
Days of Payables Outstanding
 33.70 26.71 40.98 31.03 27.87
Operating Cycle
 402.41 331.83 327.31 263.33 229.79
Cash Flow Ratios
Operating Cash Flow Per Share
 3.51 3.41 4.10 3.35 3.19
Free Cash Flow Per Share
 3.28 3.07 3.87 3.02 2.53
CapEx Per Share
 0.24 0.34 0.23 0.33 0.66
Free Cash Flow to Operating Cash Flow
 0.93 0.90 0.94 0.90 0.79
Dividend Paid and CapEx Coverage Ratio
 14.96 9.91 17.81 10.20 4.83
Capital Expenditure Coverage Ratio
 14.96 9.91 17.81 10.20 4.83
Operating Cash Flow Coverage Ratio
 14.49 0.33 0.30 0.26 0.19
Operating Cash Flow to Sales Ratio
 0.19 0.21 0.27 0.23 0.22
Free Cash Flow Yield
12.64%11.85%20.52%8.94%6.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 106.31 163.97 -8.75 37.17 110.48
Price-to-Sales (P/S) Ratio
 1.31 1.59 1.24 2.31 2.64
Price-to-Book (P/B) Ratio
 1.51 1.66 1.12 1.79 2.27
Price-to-Free Cash Flow (P/FCF) Ratio
 7.24 8.44 4.87 11.18 15.26
Price-to-Operating Cash Flow Ratio
 6.95 7.59 4.60 10.08 12.10
Price-to-Earnings Growth (PEG) Ratio
 -1.88 -1.53 0.03 0.23 -1.75
Price-to-Fair Value
 1.51 1.66 1.12 1.79 2.27
Enterprise Value Multiple
 8.63 12.17 42.36 12.89 17.22
Enterprise Value
 1.38B 1.45B 1.23B 1.99B 2.42B
EV to EBITDA
 11.31 12.17 42.36 12.89 17.22
EV to Sales
 1.90 2.00 1.76 2.95 3.62
EV to Free Cash Flow
 10.08 10.60 6.90 14.28 20.98
EV to Operating Cash Flow
 9.06 9.53 6.51 12.88 16.64
Tangible Book Value Per Share
 6.94 6.84 7.62 4.84 1.56
Shareholders’ Equity Per Share
 16.16 15.55 16.83 18.83 17.03
Tax and Other Ratios
Effective Tax Rate
 0.29 0.58 -0.58 0.32 -0.20
Revenue Per Share
 18.16 16.30 15.16 14.60 14.65
Net Income Per Share
 0.23 0.16 -2.15 0.91 0.35
Tax Burden
 0.42 0.42 1.58 0.68 1.20
Interest Burden
 0.55 0.60 1.27 0.78 0.27
Research & Development to Revenue
 0.16 0.16 0.12 0.11 0.13
SG&A to Revenue
 0.51 0.51 0.42 0.17 0.16
Stock-Based Compensation to Revenue
 0.08 0.08 0.07 0.07 0.07
Income Quality
 21.61 21.61 -1.90 3.69 9.13
Currency in USD